Treatment of Anemia in Patients With Cancer Who Are Not Currently Receiving Chemotherapy or Radiotherapy
2 other identifiers
interventional
N/A
1 country
12
Brief Summary
The purpose of this study is to determine the effectiveness of different doses of epoetin alfa for treating anemia in patients who have cancer; or patients who no longer have any signs of cancer, but remain anemic as a result of their treatment. These patients should not be currently receiving chemotherapy or radiotherapy. A subject's participation in the study will last approximately 6 months. Subjects will receive weekly doses of epoetin alfa or placebo. Their hemoglobin will be tested every week.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Feb 2004
Shorter than P25 for phase_3
12 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2004
CompletedFirst Submitted
Initial submission to the registry
May 24, 2004
CompletedFirst Posted
Study publicly available on registry
May 27, 2004
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2004
CompletedApril 27, 2011
April 1, 2011
May 24, 2004
April 25, 2011
Conditions
Interventions
Eligibility Criteria
You may qualify if:
- Body weight \>/=99 lbs
- ECOG 0-2
- Anemia results from cancer, chemotherapy, radiotherapy or an association with hormonal therapy or immunotherapy
- Screening hemoglobin level of \</=11.0 g/dL for men or \</=10.0 for women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (12)
Heritage Physician Group-Oncology
Hot Springs, Arkansas, 71913, United States
Spalding Oncology Services
Griffin, Georgia, 30224, United States
Southern Illinois Hematology
Centralia, Illinois, 62801, United States
BioLab Research
Rockville, Maryland, 20852, United States
Slocum-Dickson Medical Group, PC
New Hartford, New York, 13413, United States
NorthEast Urology Research
Concord, North Carolina, United States
Mid Ohio Oncology Hematology
Columbus, Ohio, 43213, United States
Drexel University College of Medicine
Philadelphia, Pennsylvania, 19102, United States
Caroline Cancer Center
Aiken, South Carolina, 29403, United States
Charleston Hematology Oncology
Charleston, South Carolina, 29403, United States
Charleston Cancer Care
Charleston, South Carolina, 29406, United States
Volunteer Research Group
Knoxville, Tennessee, 37920, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Purpose
- TREATMENT
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
May 24, 2004
First Posted
May 27, 2004
Study Start
February 1, 2004
Study Completion
October 1, 2004
Last Updated
April 27, 2011
Record last verified: 2011-04